Five Portuguese Management Master's Programs Among the Best in the World. And One of Them Ranks 2nd
Business
Образование

Five Portuguese Management Master's Programs Among the Best in the World. And One of Them Ranks 2nd

SAPO Notícias7 September 2026 at 07:15

Five Portuguese business schools are among the best in the world in Management master's programs, according to the Financial Times Masters in Management 2026 ranking, published by the British newspaper "Financial Times". One of these schools ranks second in the ranking, standing out among world-reference institutions in this area. The ranking was released today, September 7th, and evaluates master's programs in Management offered by business schools from various countries. This result represents a significant recognition of the quality of management education in Portugal and the positioning of Portuguese schools in the international academic landscape.

Related articles

Business

Venezuela respects oil agreements with China and Russia

Venezuela's Hydrocarbons Minister assured that Chinese and Russian companies will continue to operate in the country, guaranteeing compliance with existing oil agreements. This guarantee comes after an agreement with the United States that allows American exploitation of a fifth of Venezuela's oil reserves.

Observador07/09/26, 08:08
Business

Fuel prices with big increase this Monday

Fuel prices rise again this Monday, with diesel increasing by about 15 cents per liter and simple 95 gasoline by approximately 12 cents. This update reflects the appreciation of oil in international markets and current geopolitical instability.

Rádio Alto Minho07/09/26, 08:07
Business

Biovance Capital leads 11 million euro round in Spanish Vaxdyn

The Portuguese venture capital firm Biovance Capital led an €11 million Series A funding round in the Spanish biotech company Vaxdyn, investing four million euros. The operation also counted on participation from the European Innovation Council fund and the Impacto Andalucía Innovación y Desarrollo fund. The funding will allow Vaxdyn to advance to Phase 1 clinical trials of its K-VAX vaccine, aimed at preventing infections by antibiotic-resistant bacteria such as Klebsiella pneumoniae and Acinetobacter baumannii. The company, based in Seville, develops vaccines using a proprietary platform, and faces a global health problem that causes approximately five million deaths annually worldwide, which could double by 2050. For Biovance Capital, this is the third investment from its €60 million fund dedicated to biotechnology in Southern Europe.

Jornal Económico07/09/26, 08:00
Business

Espaço Empresa reopens today in Leiria

The Business Space resumes its operation today at the municipal market in Leiria, after a period of interruption.

Diário de Leiria07/09/26, 08:00